131 related articles for article (PubMed ID: 397714)
1. Plasma renin activity and mineralocorticoid replacement therapy in congenital adrenal hyperplasia.
Sólyom J; Gaál K
Acta Paediatr Acad Sci Hung; 1979; 20(2-3):229-35. PubMed ID: 397714
[TBL] [Abstract][Full Text] [Related]
2. Neonatal salt loss in the hypertensive form of congenital adrenal hyperplasia.
Holcombe JH; Keenan BS; Nichols BL; Kirkland RT; Clayton GW
Pediatrics; 1980 Apr; 65(4):777-81. PubMed ID: 6966049
[TBL] [Abstract][Full Text] [Related]
3. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
Hochberg Z; Benderly A; Kahana L; Zadik Z
J Clin Endocrinol Metab; 1986 Jul; 63(1):36-40. PubMed ID: 3011843
[TBL] [Abstract][Full Text] [Related]
4. Plasma renin activity and the response to sodium depletion in salt-losing congenital adrenal hyperplasia.
Keenan BS; Holcombe JH; Wilson DP; Kirkland RT; Potts E; Clayton GW
Pediatr Res; 1982 Feb; 16(2):118-22. PubMed ID: 7036075
[No Abstract] [Full Text] [Related]
5. Plasma renin activity in congenital virilizing adrenal hyperplasia.
Imai M; Igarashi Y; Sokabe H
Pediatrics; 1968 May; 41(5):897-904. PubMed ID: 5654837
[No Abstract] [Full Text] [Related]
6. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
7. [Aggravation of salt loss due to hydrocortisone in the first days of treatment of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency].
Bey-Omar F; Feit JP; Forest MG; David M
Pediatrie; 1983 Mar; 38(2):77-86. PubMed ID: 6622141
[TBL] [Abstract][Full Text] [Related]
8. Plasma renin activity in the management of congenital adrenal hyperplasia.
Griffiths KD; Anderson JM; Rudd BT; Virdi NK; Holder G; Rayner PH
Arch Dis Child; 1984 Apr; 59(4):360-5. PubMed ID: 6372706
[TBL] [Abstract][Full Text] [Related]
9. Enzyme immunoassay for plasma renin activity: II. Clinical application.
Hubl W; Büchner M; Schmidt PK; Garten CD; Dörner G
Endokrinologie; 1981 Oct; 78(1):99-106. PubMed ID: 7032898
[TBL] [Abstract][Full Text] [Related]
10. Value of direct measurement of active renin concentrations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Krüger C; Höper K; Weissörtel R; Hensen J; Dörr HG
Eur J Pediatr; 1996 Oct; 155(10):858-61. PubMed ID: 8891554
[TBL] [Abstract][Full Text] [Related]
11. Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia.
Godard C; Riondel AM; Veyrat R; Mégevand A; Muller AF
Pediatrics; 1968 May; 41(5):883-904. PubMed ID: 5654836
[No Abstract] [Full Text] [Related]
12. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Irony I; Cutler GB
Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
[TBL] [Abstract][Full Text] [Related]
13. Reinstitution of mineralocorticoid therapy in congenital adrenal hyperplasia. Effects on control and growth.
Jansen M; Wit JM; van den Brande JL
Acta Paediatr Scand; 1981 Mar; 70(2):229-33. PubMed ID: 7015786
[TBL] [Abstract][Full Text] [Related]
14. Congenital pseudohypoaldosteronism: case report and review. Effect of indomethacin during sodium chloride depletion.
Rampini S; Furrer J; Keller HP; Bucher H; Zachmann M
Helv Paediatr Acta; 1978 Jun; 33(2):153-67. PubMed ID: 659259
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase.
Speiser PW; Agdere L; Ueshiba H; White PC; New MI
N Engl J Med; 1991 Jan; 324(3):145-9. PubMed ID: 1984191
[TBL] [Abstract][Full Text] [Related]
16. [State of the renin-angiotensin system in children with different clinical variants of congenital adrenal cortex hyperplasia caused by 21-hydroxylase deficiency].
Kasatkina EP; Tiul'pakov AN; Goriaĭnova II
Pediatriia; 1992; (2):35-40. PubMed ID: 1513631
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia.
Nimkarn S; Lin-Su K; Berglind N; Wilson RC; New MI
J Clin Endocrinol Metab; 2007 Jan; 92(1):137-42. PubMed ID: 17032723
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia.
Schaison G; Couzinet B; Gourmelen M; Elkik F; Bougneres P
J Clin Endocrinol Metab; 1980 Dec; 51(6):1390-4. PubMed ID: 7002950
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure, fludrocortisone dose and plasma renin activity in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency followed from birth to 4 years of age.
Bonfig W; Schwarz HP
Clin Endocrinol (Oxf); 2014 Dec; 81(6):871-5. PubMed ID: 24818525
[TBL] [Abstract][Full Text] [Related]
20. The effects of long-term normalization of sodium balance on linear growth in disorders with aldosterone deficiency.
Kuhnle U; Rösler A; Pareira JA; Gunzcler P; Levine LS; New MI
Acta Endocrinol (Copenh); 1983 Apr; 102(4):577-82. PubMed ID: 6342327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
